rs121913585
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_000530.8(MPZ):c.188C>T(p.Ser63Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S63C) has been classified as Pathogenic.
Frequency
Consequence
NM_000530.8 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 1BInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet
- neuropathy, congenital hypomyelinating, 2Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
- autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic painInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease dominant intermediate DInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 2IInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 2JInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-Tooth disease type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MPZ | NM_000530.8 | c.188C>T | p.Ser63Phe | missense_variant | Exon 2 of 6 | ENST00000533357.5 | NP_000521.2 | |
| MPZ | NM_001315491.2 | c.188C>T | p.Ser63Phe | missense_variant | Exon 2 of 6 | NP_001302420.1 | ||
| MPZ | XM_017001321.3 | c.218C>T | p.Ser73Phe | missense_variant | Exon 2 of 6 | XP_016856810.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease Pathogenic:1
- -
Charcot-Marie-Tooth disease type 1B Pathogenic:1
- -
Charcot-Marie-Tooth disease, type I Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 63 of the MPZ protein (p.Ser63Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 8835320, 15050444, 17294201). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 14177). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MPZ protein function. Experimental studies have shown that this missense change affects MPZ function (PMID: 20461396). This variant disrupts the p.Ser63 amino acid residue in MPZ. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7506095, 16495463, 20937820). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at